Aeglea
is a pharmaceutical company that researches and develops enzyme-based therapeutics for the treatment of cancer and rare genetic diseases... Read moreAeglea
is a pharmaceutical company that researches and develops enzyme-based therapeutics for the treatment of cancer and rare genetic diseases... Read more
News
Mar 01, 2024
Owler
Aeglea Biotherapeutics, Inc.: Aeglea's revenue changed from $1.05M in Sep 2023 to $886K in Dec 2023
Nov 24, 2023
MarketScreener
Aeglea: Aeglea BioTherapeutics : Submission of Matters to a Vote of Security Holders - Form 8-K
Nov 15, 2023
MarketScreener
Aeglea: Aeglea BioTherapeutics : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 8-K
Nov 10, 2023
Owler
Aeglea Biotherapeutics, Inc.: Aeglea's revenue changed from $1.23M in Jun 2023 to $1.05M in Sep 2023
Sep 07, 2023
Citybizlist
Aeglea: Aeglea BioTherapeutics Announces Reverse Stock Split
Aug 11, 2023
BioSpace
Aeglea: Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results
Aug 11, 2023
Owler
Aeglea Biotherapeutics, Inc.: Aeglea's revenue changed from $1.17M in Mar 2023 to $1.23M in Jun 2023
Aug 02, 2023
Global Legal Chronicle
Aeglea: Immedica Pharma's Acquisition of Pegzilarginase Assets from Aeglea
Jun 22, 2023
Proactive Investors
Aeglea: Aeglea BioTherapeutics stock skyrockets as it boosts inflammatory bowel disease portfolio with Spyre Therapeutics acquisition
Apr 12, 2023
Benzinga
Aeglea: Why Are Aeglea BioTherapeutics Shares Sinking Today?
Aeglea Competitors
1
2
3
4
5
6
7
8
9
10